JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 11 July 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00313-07v1
81/18/10161    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wati, S.
Right arrow Articles by Carr, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wati, S.
Right arrow Articles by Carr, J. M.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00313-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Dengue virus (DV) replication in monocyte-derived-macrophages is not affected by TNF-{alpha}, and DV infection induces altered responsiveness to TNF-{alpha} stimulation

Satiya Wati*, Peng Li, Christopher J. Burrell, and Jillian M. Carr

School of Molecular and Biomedical Science, University of Adelaide, SA 5005, Australia; Infectious Diseases laboratories, Institute of Medical and Veterinary Science, Adelaide, SA 5000, Australia

* To whom correspondence should be addressed. Email: satiya.wati{at}imvs.sa.gov.au.


   Abstract

Tumour necrosis factor alpha (TNF-{alpha}) is believed to play a significant role in the pathogenesis of dengue virus (DV) infection with elevated levels of TNF-{alpha} in the sera of DV infected patients that parallel the severity of disease and TNF-{alpha} release is coincident with the peak of DV production from infected monocyte-derived-macrophages (MDM) in vitro. Since macrophages are a primary cell target in vivo for DV infection, we investigated the potential antiviral role of TNF-{alpha} in regulating DV replication in MDM. While pre-treatment of MDM with TNF-{alpha} had a minor inhibitory effect, addition of TNF-{alpha} to MDM with established DV infection had no effect on DV replication as measured by DV RNA levels or progeny virus production. Blocking endogenous TNF-{alpha} using siRNA or inhibitory TNF-{alpha} antibodies also had no effect on infectious DV production or viral RNA synthesis. Together, these results demonstrate that DV replication in MDM is not affected by TNF-{alpha}. Additionally, normal cellular TNF-{alpha} signalling, measured by quantitation of TNF-{alpha}-induced stimulation of transcription from a NF-kappa B (NF-kB) responsive reporter plasmid or NF-kB protein nuclear translocation, was blocked in DV infected MDM and Huh7 cells. Thus, DV replication in MDM is not affected by TNF-{alpha}, and infected cells do not respond normally to TNF-{alpha} stimulation. It is therefore unlikely that the increased production of TNF-{alpha} seen in DV infection directly effects DV clearance by reducing DV replication and the ability of DV to alter TNF-{alpha} responsiveness highlights another example of viral subversion of cellular functions.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.